本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corcept醫療

112.66
+0.85000.76%
成交量:34.54萬
成交額:3,883.36萬
市值:121.78億
市盈率:248.34
高:114.00
開:113.18
低:111.07
收:111.81
52周最高:126.38
52周最低:28.66
股本:1.08億
流通股本:9,644.01萬
量比:0.44
換手率:0.36%
股息:- -
股息率:- -
每股收益(TTM):0.4537
每股收益(LYR):0.8200
淨資產收益率:8.23%
總資產收益率:0.47%
市淨率:17.26
市盈率(LYR):137.39

資料載入中...

2024/05/01

重要事件披露

Form 8-K - Current report
2024/05/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/02

重要事件披露

Form 8-K - Current report
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities